Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis

Autor: Kf, Laserson, Le, Thorpe, Leimane V, Weyer K, Cd, Mitnick, Riekstina V, Zarovska E, Ml, Rich, Hamish Fraser, Alarcón E, Jp, Cegielski, Grzemska M, Gupta R, Espinal M

Publikováno v: Europe PubMed Central

Globally it is estimated that 273000 new cases of multidrug-resistant tuberculosis (MDR-TB, resistance to isoniazid and rifampicin) occurred in 2000. To address MDR-TB management in the context of the DOTS strategy, the World Health Organization and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6e0b5c68160707e8f3fb911e37cba3c6
https://pubmed.ncbi.nlm.nih.gov/15971391

Cost-Effectiveness and Cost-Benefit Analyses of Providing Menstrual Cups and Sanitary Pads to Schoolgirls in Rural Kenya.

Autor: Babagoli MA; Department of Economics, Barnard College, Columbia University, New York, USA., Benshaul-Tolonen A; Department of Economics, Barnard College, Columbia University, New York, USA., Zulaika G; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Nyothach E; Centre for Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Oduor C; Centre for Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Obor D; Centre for Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Mason L; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Kerubo E; Centre for Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Ngere I; County Health Headquarters, Ministry of Health, Siaya County, Kenya., Laserson KF; Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Tudor Edwards R; Centre for Health Economics and Medicines Evaluations, Bangor University, Bangor, United Kingdom., Phillips-Howard PA; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Publikováno v: Women's health reports (New Rochelle, N.Y.) [Womens Health Rep (New Rochelle)] 2022 Sep 15; Vol. 3 (1), pp. 773-784. Date of Electronic Publication: 2022 Sep 15 (Print Publication: 2022).

Development of a TB vaccine trial site in Africa and lessons from the Ebola experience.

Autor: Kaguthi G; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya. gkaguthi@kemri.org.; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. gkaguthi@kemri.org.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya. gkaguthi@kemri.org., Nduba V; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya., Rabuogi P; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya., Okelloh D; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya., Ouma SG; Centre for Respiratory Diseases Research-Kenya Medical Research Institute (KEMRI-CRDR), Nairobi, Kenya.; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya., Blatner G; AERAS (at the time of the studies), Cape Town, South Africa.; AERAS (at the time of the studies), Rockville, Maryland, USA., Gelderbloem S; AERAS (at the time of the studies), Cape Town, South Africa.; AERAS (at the time of the studies), Rockville, Maryland, USA., Mitchell EMH; Institute of Tropical Medicine, Antwerp, Belgium.; (at the time of the studies) KNCV Tuberculosis Foundation, The Hague, The Netherlands., Scott CP; AERAS (at the time of the studies), Cape Town, South Africa.; AERAS (at the time of the studies), Rockville, Maryland, USA., Verver S; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; (at the time of the studies) KNCV Tuberculosis Foundation, The Hague, The Netherlands., Hawkridge T; AERAS (at the time of the studies), Cape Town, South Africa.; AERAS (at the time of the studies), Rockville, Maryland, USA., de Steenwinkel JEM; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Laserson KF; (at the time of the studies) KEMRI and Centers for Disease Control and Prevention Public Health Collaboration, Kisumu, Kenya., Richardus JH; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publikováno v: BMC public health [BMC Public Health] 2020 Jun 26; Vol. 20 (1), pp. 999. Date of Electronic Publication: 2020 Jun 26.

Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of Infection.

Autor: Arunkumar G; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Devadiga S; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., McElroy AK; Centers for Disease Control and Prevention, Atlanta, Georgia.; Department of Pediatrics, University of Pittsburgh, Pennsylvania., Prabhu S; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Sheik S; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Abdulmajeed J; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Robin S; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Sushama A; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Jayaram A; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Nittur S; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Shakir M; Manipal Centre for Virus Research, Manipal Academy of Higher Education, Karnataka, India., Kumar KGS; Government Medical College, Kozhikode, Kerala., Radhakrishnan C; Government Medical College, Kozhikode, Kerala., Sakeena K; Directorate of Health Services, Government of Kerala, Thiruvananthapuram, India., Vasudevan J; Directorate of Health Services, Government of Kerala, Thiruvananthapuram, India., Reena KJ; Directorate of Health Services, Government of Kerala, Thiruvananthapuram, India., Sarita RL; Directorate of Health Services, Government of Kerala, Thiruvananthapuram, India., Klena JD; Centers for Disease Control and Prevention, Atlanta, Georgia., Spiropoulou CF; Centers for Disease Control and Prevention, Atlanta, Georgia., Laserson KF; Centers for Disease Control and Prevention, Atlanta, Georgia., Nichol ST; Centers for Disease Control and Prevention, Atlanta, Georgia.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Oct 30; Vol. 69 (10), pp. 1752-1756.

Jaundice outbreak likely caused by HEV in Amritsar, Punjab, India, 2013.

Autor: Kumar T; National Centre for Disease Control, 22-Sham Nath Marg, Delhi, 110054, India. tripurarikumareis2012@gmail.com., Shrivastava A; National Centre for Disease Control, 22-Sham Nath Marg, Delhi, 110054, India., Bhatia D; Department of Health and Family Welfare, Chandigarh, Punjab, India., Mitra Y; Department of Health and Family Welfare, Chandigarh, Punjab, India., Kumar A; National Centre for Disease Control, 22-Sham Nath Marg, Delhi, 110054, India., Hussain S; Emory University, Atlanta, GA, USA., Chauhan LS; National Centre for Disease Control, 22-Sham Nath Marg, Delhi, 110054, India., Laserson KF; India-Centers for Disease Control and Prevention, Delhi, India.; Centers for Disease Control and Prevention, Atlanta, USA., Narain JP; National Centre for Disease Control, 22-Sham Nath Marg, Delhi, 110054, India., Kumar R; Post Graduate Institute of Medical Education & Research, Chandigarh, India., Francisco A; Centers for Disease Control and Prevention, Atlanta, USA.

Publikováno v: BMC public health [BMC Public Health] 2019 May 10; Vol. 19 (Suppl 3), pp. 464. Date of Electronic Publication: 2019 May 10.